Abstract
An early, extensive, accurate, and cost-effective clinical diagnosis of neurocognitive disorders will have advantages for older people and their families, but also for the health and care systems sustainability and performance. BRAINCODE is a technology that assesses cognitive impairment in older people, differentiating normal from pathologic brain condition, based in an EEG biomarkers evaluation. This paper will address BRAINCODE’s pilot design, which intends to validate its efficacy, to provide guidelines for future studies and to allow its integration on the SHAPES platform. It is expected that BRAINCODE confirms a regular clinical diagnosis and neuropsychologic tests to discriminate ‘normal’ from pathologic cognitive decline and differentiates mild cognitive impairment from dementia in older adults with/without subjective cognitive complains.
Funder
European Union's Horizon 2020 research and innovation programme
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health
Reference38 articles.
1. United Nations Decade of Healthy Ageing (2021–2030)https://documents-dds-ny.un.org/doc/UNDOC/GEN/N20/363/87/PDF/N2036387.pdf?OpenElement
2. Global Status Report on the Public Health Response to Dementia,2021
3. Psychological distress, loneliness and disability in old age
4. Cognitive impairment in old people living in the community
5. Predictors of Major Depressive Disorder in Older People
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献